Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.140 | 1.290 | 0.150 |
Stocks | 98.860 | 98.860 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.486 | 18.162 |
Price to Book | 2.883 | 3.380 |
Price to Sales | 1.974 | 2.160 |
Price to Cash Flow | 14.037 | 14.404 |
Dividend Yield | 3.270 | 2.912 |
5 Years Earnings Growth | 16.662 | 13.138 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 34.460 | 30.833 |
Financial Services | 27.450 | 20.143 |
Industrials | 12.980 | 16.549 |
Consumer Defensive | 12.420 | 13.058 |
Technology | 4.720 | 3.482 |
Consumer Cyclical | 4.290 | 5.097 |
Communication Services | 2.810 | 2.868 |
Basic Materials | 0.870 | 8.631 |
Number of long holdings: 45
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 9.55 | 249.90 | +1.01% | |
Novartis | CH0012005267 | 9.44 | 87.47 | +0.86% | |
Nestle | CH0038863350 | 9.43 | 74.04 | +0.08% | |
Zurich Insurance Group | CH0011075394 | 7.80 | 538.00 | +0.94% | |
UBS Group | CH0244767585 | 4.80 | 26.98 | +1.01% | |
ABB | CH0012221716 | 4.71 | 49.10 | +0.49% | |
Swiss Re | CH0126881561 | 4.60 | 129.55 | +0.82% | |
Lonza Group | CH0013841017 | 4.49 | 534.40 | +0.64% | |
Swiss Life Holding | CH0014852781 | 3.88 | 694.00 | +0.81% | |
Alcon | CH0432492467 | 3.71 | 76.38 | +0.47% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS Strategy Fund Yield CHF K 1 acc | 1.58B | 2.70 | -3.28 | 0.65 | ||
UBS Strategy Fund Growth CHF Q acc | 651.02M | 8.48 | -0.46 | 3.09 | ||
UBS Equity S European High Dividend | 151.04M | 5.25 | 2.39 | 2.50 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review